BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7690710)

  • 21. Oncogene Expression and Cellular Radiation Resistance: A Modulatory Role for c-myc.
    Chiang CS; Sawyers CL; Mcbride WH
    Mol Diagn; 1998 Mar; 3(1):21-27. PubMed ID: 10096954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. v-erbA cooperates with bFGF in neuroretina cell transformation.
    Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S
    Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
    Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
    Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
    Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
    Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
    Fan H; Villegas C; Huang A; Wright JA
    Cancer Res; 1998 Apr; 58(8):1650-3. PubMed ID: 9563477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
    Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
    Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells.
    Cosgaya JM; Aranda A
    Oncogene; 1996 Jun; 12(12):2651-60. PubMed ID: 8700524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RalA mediates v-Src, v-Ras, and v-Raf regulation of CD44 and fibronectin expression in NIH3T3 fibroblasts.
    Ladeda V; Frankel P; Feig LA; Foster DA; Bal de Kier Joffe E; Aguirre-Ghiso JA
    Biochem Biophys Res Commun; 2001 May; 283(4):854-61. PubMed ID: 11350063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum growth factors up-regulate H-ras, K-ras, and N-ras proto-oncogenes in fibroblasts.
    Quincoces AF; León J
    Cell Growth Differ; 1995 Mar; 6(3):271-9. PubMed ID: 7794795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. V-sis induces Egr-1 expression by a pathway mediated by c-Ha-Ras.
    Huang RP; Ngo L; Okamura D; Tucker M; Adamson ED
    J Cell Biochem; 1994 Dec; 56(4):469-79. PubMed ID: 7890805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of cell transformation by mutated 16K vacuolar H+-atpase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells.
    Saito T; Schlegel R; Andresson T; Yuge L; Yamamoto M; Yamasaki H
    Oncogene; 1998 Oct; 17(13):1673-80. PubMed ID: 9796696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of focal adhesion kinase at Tyrosine 407 negatively regulates Ras transformation of fibroblasts.
    Jeon J; Lee H; Park H; Lee JH; Choi S; Hwang J; Han IO; Oh ES
    Biochem Biophys Res Commun; 2007 Dec; 364(4):1062-6. PubMed ID: 17976369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. v-Ras and v-Raf block differentiation of transformable C3H10T1/2-derived preadipocytes at lower levels than required for neoplastic transformation.
    Raptis L; Brownell HL; Lu Y; Preston T; Narsimhan RP; Anderson S; Schaefer E; Haliotis T
    Exp Cell Res; 1997 Aug; 235(1):188-97. PubMed ID: 9281368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.
    Langdon WY; Harris AW; Cory S
    Oncogene Res; 1989; 4(4):253-8. PubMed ID: 2549487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant transformation of a human fibroblast cell strain by transfection of a v-fes oncogene but not by transfection of a gag-human c-fes construct.
    Lin C; Wang Q; Maher VM; McCormick JJ
    Cell Growth Differ; 1994 Dec; 5(12):1381-7. PubMed ID: 7696187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo and in vitro effects of v-fos and EJ-Ha-ras oncogene expression in murine epidermal keratinocytes.
    Appleby MW; Greenfield IM; Crook T; Parkinson EK; Stanley MA
    Oncogene; 1989 Nov; 4(11):1323-30. PubMed ID: 2682460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial characterization of protein tyrosine kinases in human lymphoid cells.
    Punt CJ; Rijksen G; van Oirschot BA; Kester-Schipper GP; van der Heijden MC; Dekker AW; Staal GE
    Anticancer Res; 1992; 12(6B):2075-84. PubMed ID: 1284200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.